Published in Transgenic Res on October 01, 2005
Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol (2006) 1.35
The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20
Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase-mediated excision/recombination. Mol Microbiol (2009) 1.17
Endopeptidase and glycosidase activities of the bacteriophage B30 lysin. Appl Environ Microbiol (2006) 1.10
Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans. FEBS J (2014) 0.90
A critical analysis of disease-associated DNA polymorphisms in the genes of cattle, goat, sheep, and pig. Mamm Genome (2008) 0.86
Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris. Appl Environ Microbiol (2014) 0.85
Genome engineering in cattle: recent technological advancements. Chromosome Res (2015) 0.85
Association of toll-like receptor four single nucleotide polymorphisms with incidence of infectious bovine keratoconjunctivitis (IBK) in cattle. Immunogenetics (2010) 0.84
Identification of short hairpin RNA targeting foot-and-mouth disease virus with transgenic bovine fetal epithelium cells. PLoS One (2012) 0.83
Germline modification of domestic animals. Anim Reprod (2016) 0.77
Stem cell research: a novel boulevard towards improved bovine mastitis management. Int J Biol Sci (2013) 0.77
Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol (2005) 2.14
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun (2005) 1.51
Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect Immun (2006) 1.05
Cryopreserved bovine mammary cells to model epithelial response to infection. Vet Immunol Immunopathol (2004) 1.01
Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis. Vet Microbiol (2007) 0.91
Characterization of the infection-responsive bovine lactoferrin promoter. Gene (2005) 0.85
Reductively activated disulfide prodrugs of paclitaxel. Bioorg Med Chem Lett (2002) 0.81
Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein. Bioorg Med Chem Lett (2003) 0.81
Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide. BMC Genomics (2009) 0.79
Assurance enzyme immunoassay eight hour method for detection of enterohemorrhagic Escherichia coli O157:H7 in raw and cooked beef (modification of AOAC Official Method 996.10): collaborative study. J AOAC Int (2002) 0.78
Comparison of gene expression in individual preimplantation bovine embryos produced by in vitro fertilisation or somatic cell nuclear transfer. Reprod Fertil Dev (2005) 0.77
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 999.09 [Visual Immunoprecipitate (VIP) for Salmonella] to the reference culture methods. J AOAC Int (2008) 0.75
Visual immunoprecipitate assay eight hour method for detection of enterohemorrhagic Escherichia coli O157:H7 in raw and cooked beef (modification of AOAC Official Method 996.09): collaborative study. J AOAC Int (2002) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC official method 2005.04 assurance GdS E. coli 0157:H7 method to the reference culture method: 375 gram sample size. J AOAC Int (2013) 0.75
Evaluation of the assurance GDS for E. coli O157:H7 method and assurance GDS for shigatoxin genes method in selected foods: collaborative study. J AOAC Int (2006) 0.75
Molecular characterization of lysozyme type II gene in rainbow trout (Oncorhynchus mykiss): evidence of gene duplication. Anim Biotechnol (2003) 0.75
Expression of lysostaphin in milk of transgenic mice affects the growth of neonates. Transgenic Res (2003) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 996.09 Visual Immunoprecipitate (VIP) for E. coli O157:H7 method to the reference culture method. J AOAC Int (2009) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 997.03 Visual Immunoprecipitate (VIP) for Listeria to the reference culture method. J AOAC Int (2009) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 996.09 [Visual Immunoprecipitate (VIP) for E. coli O157:H7] to the reference culture methods. J AOAC Int (2008) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 997.03 [Visual Immunoprecipitate (VIP) for Listeria] to the reference culture methods. J AOAC Int (2008) 0.75
Comparative validation study to demonstrate the equivalence of a minor modification to AOAC Method 999.09 Visual Immunoprecipitate (VIP) for Salmonella method to the reference culture method. J AOAC Int (2009) 0.75
Evaluation of the Assurance GDS for Salmonella method in foods and environmental surfaces: multilaboratory collaborative study. J AOAC Int (2010) 0.75